Blazar BR - Search Results

1

Clinical application of expanded CD4+25+ cells.

June CH, Blazar BR. June CH, et al. Among authors: blazar br. Semin Immunol. 2006 Apr;18(2):78-88. doi: 10.1016/j.smim.2006.01.006. Epub 2006 Feb 2. Semin Immunol. 2006. PMID: 16458015 Review.

2

Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta.

Zeller JC, Panoskaltsis-Mortari A, Murphy WJ, Ruscetti FW, Narula S, Roncarolo MG, Blazar BR. Zeller JC, et al. Among authors: blazar br. J Immunol. 1999 Oct 1;163(7):3684-91. J Immunol. 1999. PMID: 10490963

3

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

Taylor PA, Lees CJ, Blazar BR. Taylor PA, et al. Among authors: blazar br. Blood. 2002 May 15;99(10):3493-9. doi: 10.1182/blood.v99.10.3493. Blood. 2002. PMID: 11986199 Free article.

4

In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures.

Godfrey WR, Ge YG, Spoden DJ, Levine BL, June CH, Blazar BR, Porter SB. Godfrey WR, et al. Among authors: blazar br. Blood. 2004 Jul 15;104(2):453-61. doi: 10.1182/blood-2004-01-0151. Epub 2004 Mar 18. Blood. 2004. PMID: 15031211 Free article.

5

A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cells.

Sauer MG, Ericson ME, Weigel BJ, Herron MJ, Panoskaltsis-Mortari A, Kren BT, Levine BL, Serody JS, June CH, Taylor PA, Blazar BR. Sauer MG, et al. Among authors: blazar br. Cancer Res. 2004 Jun 1;64(11):3914-21. doi: 10.1158/0008-5472.CAN-03-3991. Cancer Res. 2004. PMID: 15173002

6

L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.

Taylor PA, Panoskaltsis-Mortari A, Swedin JM, Lucas PJ, Gress RE, Levine BL, June CH, Serody JS, Blazar BR. Taylor PA, et al. Among authors: blazar br. Blood. 2004 Dec 1;104(12):3804-12. doi: 10.1182/blood-2004-05-1850. Epub 2004 Aug 3. Blood. 2004. PMID: 15292057 Free article.

7

CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease.

Blazar BR, Levy RB, Mak TW, Panoskaltsis-Mortari A, Muta H, Jones M, Roskos M, Serody JS, Yagita H, Podack ER, Taylor PA. Blazar BR, et al. J Immunol. 2004 Sep 1;173(5):2933-41. doi: 10.4049/jimmunol.173.5.2933. J Immunol. 2004. PMID: 15322151

8

Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function.

Godfrey WR, Spoden DJ, Ge YG, Baker SR, Liu B, Levine BL, June CH, Blazar BR, Porter SB. Godfrey WR, et al. Among authors: blazar br. Blood. 2005 Jan 15;105(2):750-8. doi: 10.1182/blood-2004-06-2467. Epub 2004 Sep 16. Blood. 2005. PMID: 15374887 Free article.

9

Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system.

Huang X, Wilber AC, Bao L, Tuong D, Tolar J, Orchard PJ, Levine BL, June CH, McIvor RS, Blazar BR, Zhou X. Huang X, et al. Among authors: blazar br. Blood. 2006 Jan 15;107(2):483-91. doi: 10.1182/blood-2005-05-2133. Epub 2005 Sep 27. Blood. 2006. PMID: 16189271 Free PMC article.

10

Suppressor function of umbilical cord blood-derived CD4+CD25+ T-regulatory cells exposed to graft-versus-host disease drugs.

Porter SB, Liu B, Rogosheske J, Levine BL, June CH, Kohl VK, Wagner JE, Miller JS, Blazar BR. Porter SB, et al. Among authors: blazar br. Transplantation. 2006 Jul 15;82(1):23-9. doi: 10.1097/01.tp.0000225824.48931.af. Transplantation. 2006. PMID: 16861937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

905 results

Search Page

Filters